Huntingtons sjukdom – kliniska prövningar inger nu optimism - Vanligaste formen av ärftlig neurodegenerativ sjukdom i västvärlden ger svåra symtom och förtidig död
(2020) In Läkartidningen 117.- Abstract
Huntington's disease is an autosomal dominant neurodegenerative disease that leads to premature death. The disease is caused by a pathological CAG triplet expansion in the huntingtin gene. The disease is most common in Western populations, with onset in middle age and causing progressive motor, cognitive, and psychiatric symptoms. Currently, only symptomatic treatment is provided, but new molecular technologies may allow treatments reducing levels of mutated huntingtin.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/b3cf4f57-7caf-4859-a071-31b2f921035d
- author
- Niemelä, Valter ; Petersén, Åsa LU ; Loutfi, Ghada ; Svenningsson, Per and Paucar, Martin
- organization
- alternative title
- Recent advances in Huntington's disease
- publishing date
- 2020-03-09
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Läkartidningen
- volume
- 117
- article number
- FU7H
- publisher
- Swedish Medical Association
- external identifiers
-
- pmid:32154905
- scopus:85081633636
- ISSN
- 0023-7205
- language
- Swedish
- LU publication?
- yes
- id
- b3cf4f57-7caf-4859-a071-31b2f921035d
- alternative location
- https://lakartidningen.se/klinik-och-vetenskap-1/artiklar-1/temaartikel/2020/03/huntingtons-sjukdom-kliniska-provningar-inger-nu-optimism/
- date added to LUP
- 2020-04-01 14:41:49
- date last changed
- 2022-04-18 21:40:28
@article{b3cf4f57-7caf-4859-a071-31b2f921035d, abstract = {{<p>Huntington's disease is an autosomal dominant neurodegenerative disease that leads to premature death. The disease is caused by a pathological CAG triplet expansion in the huntingtin gene. The disease is most common in Western populations, with onset in middle age and causing progressive motor, cognitive, and psychiatric symptoms. Currently, only symptomatic treatment is provided, but new molecular technologies may allow treatments reducing levels of mutated huntingtin.</p>}}, author = {{Niemelä, Valter and Petersén, Åsa and Loutfi, Ghada and Svenningsson, Per and Paucar, Martin}}, issn = {{0023-7205}}, language = {{swe}}, month = {{03}}, publisher = {{Swedish Medical Association}}, series = {{Läkartidningen}}, title = {{Huntingtons sjukdom – kliniska prövningar inger nu optimism - Vanligaste formen av ärftlig neurodegenerativ sjukdom i västvärlden ger svåra symtom och förtidig död}}, url = {{https://lakartidningen.se/klinik-och-vetenskap-1/artiklar-1/temaartikel/2020/03/huntingtons-sjukdom-kliniska-provningar-inger-nu-optimism/}}, volume = {{117}}, year = {{2020}}, }